170 related articles for article (PubMed ID: 29598944)
1. Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer.
Kamal M; Ng SP; Eraj SA; Rock CD; Pham B; Messer JA; Garden AS; Morrison WH; Phan J; Frank SJ; El-Naggar AK; Johnson JM; Ginsberg LE; Ferrarotto R; Lewin JS; Hutcheson KA; Cardenas CE; Zafereo ME; Lai SY; Hessel AC; Weber RS; Gunn GB; Fuller CD; Mohamed ASR; Rosenthal DI
Oral Oncol; 2018 Apr; 79():1-8. PubMed ID: 29598944
[TBL] [Abstract][Full Text] [Related]
2. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
[TBL] [Abstract][Full Text] [Related]
3. Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?
Solares CA; Wood B; Rodriguez CP; Lorenz RR; Scharpf J; Saxton J; Rybicki LA; Strome M; Esclamado R; Lavertu P; Adelstein DJ
Laryngoscope; 2009 Jun; 119(6):1130-4. PubMed ID: 19358250
[TBL] [Abstract][Full Text] [Related]
4. Predicting the local outcome of glottic squamous cell carcinoma after definitive radiation therapy: value of computed tomography-determined tumour parameters.
Hermans R; Van den Bogaert W; Rijnders A; Doornaert P; Baert AL
Radiother Oncol; 1999 Jan; 50(1):39-46. PubMed ID: 10225556
[TBL] [Abstract][Full Text] [Related]
5. Oncological and functional outcomes in T3 and T4 laryngeal cancer patients: choice for larynx preservation or total laryngectomy based on expected laryngeal function.
Nobacht A; Meijer TWH; Oosting SF; van der Vegt B; Wedman J; Halmos GB; Plaat BEC
J Laryngol Otol; 2024 Jun; 138(6):672-678. PubMed ID: 38235588
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes of laryngectomy compared to non-surgical management of T
Lin DJ; Goodfellow M; Ong J; Chin MY; Lazarova L; Cocks HC
J Laryngol Otol; 2020 Dec; 134(12):1103-1107. PubMed ID: 33431081
[TBL] [Abstract][Full Text] [Related]
8. Tumor volume as a prognostic factor for local control and overall survival in advanced larynx cancer.
Timmermans AJ; Lange CA; de Bois JA; van Werkhoven E; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
Laryngoscope; 2016 Feb; 126(2):E60-7. PubMed ID: 26333005
[TBL] [Abstract][Full Text] [Related]
9. Clinical Utility of Pretreatment and 3-Month
Mayo Z; Seyedin SN; Mallak N; Mott SL; Menda Y; Graham M; Anderson C
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):595-600. PubMed ID: 30808209
[TBL] [Abstract][Full Text] [Related]
10. Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx.
Shiao JC; Mohamed ASR; Messer JA; Hutcheson KA; Johnson JM; Enderling H; Kamal M; Warren BW; Pham B; Morrison WH; Zafereo ME; Hessel AC; Lai SY; Kies MS; Ferrarotto R; Garden AS; Schomer DF; Gunn GB; Phan J; Frank SJ; Beadle BM; Weber RS; Lewin JS; Rosenthal DI; Fuller CD
Head Neck; 2017 Aug; 39(8):1609-1620. PubMed ID: 28464542
[TBL] [Abstract][Full Text] [Related]
11. Metabolic tumor volume of primary tumor predicts survival better than T classification in the larynx preservation approach.
Miyabe J; Hanamoto A; Tatsumi M; Hamasaki T; Takenaka Y; Nakahara S; Kishikawa T; Suzuki M; Takemoto N; Michiba T; Yoshioka Y; Isohashi F; Konishi K; Ogawa K; Hatazawa J; Inohara H
Cancer Sci; 2017 Oct; 108(10):2030-2038. PubMed ID: 28787757
[TBL] [Abstract][Full Text] [Related]
12. Management of advanced hypopharyngeal and laryngeal cancer with and without cartilage invasion.
Scherl C; Mantsopoulos K; Semrau S; Fietkau R; Kapsreiter M; Koch M; Traxdorf M; Grundtner P; Iro H
Auris Nasus Larynx; 2017 Jun; 44(3):333-339. PubMed ID: 27569289
[TBL] [Abstract][Full Text] [Related]
13. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
14. Clinical Predictors of Laryngeal Preservation Rate in Stage III-IV Laryngeal Cancer and Hypopharyngeal Cancer Patients Treated with Organ Preservation.
Tangsriwong K; Jitreetat T
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2051-2057. PubMed ID: 31350965
[TBL] [Abstract][Full Text] [Related]
15. Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion.
Worden FP; Moyer J; Lee JS; Taylor JM; Urba SG; Eisbruch A; Teknos TN; Chepeha DB; Prince ME; Hogikyan N; Lassig AA; Emerick K; Mukherji S; Hadjiski L; Tsien CI; Miller TH; Wallace NE; Mason HL; Bradford CR; Wolf GT
Laryngoscope; 2009 Aug; 119(8):1510-7. PubMed ID: 19504552
[TBL] [Abstract][Full Text] [Related]
16. Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?
Al-Mamgani A; Navran A; Walraven I; Schreuder WH; Tesselaar MET; Klop WMC
Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):575-583. PubMed ID: 30564952
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of thyroid or cricoid cartilage invasion in laryngeal or hypopharyngeal cancer treated with organ preserving strategies.
Wagner MM; Curé JK; Caudell JJ; Spencer SA; Nabell LM; Carroll WR; Bonner JA
Radiat Oncol; 2012 Dec; 7():219. PubMed ID: 23256610
[TBL] [Abstract][Full Text] [Related]
18. Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx.
Gorphe P; Blanchard P; Breuskin I; Temam S; Tao Y; Janot F
J Laryngol Otol; 2015 Sep; 129(9):903-9. PubMed ID: 26201253
[TBL] [Abstract][Full Text] [Related]
19. A single-institutional experience of 15 years of treating T3 laryngeal cancer with primary radiotherapy, with or without chemotherapy.
Al-Mamgani A; Tans L; van Rooij P; Levendag PC
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1000-6. PubMed ID: 22099030
[TBL] [Abstract][Full Text] [Related]
20. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy?
Pameijer FA; Mancuso AA; Mendenhall WM; Parsons JT; Kubilis PS
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1011-21. PubMed ID: 9169807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
